Survey of the impact of COVID-19 on access to STBBI-related health services including harm reduction services in Canada
The Public Health Agency of Canada wants your help to better understand how the COVID-19 pandemic has affected access to services for the care and prevention of HIV, hepatitis C and other sexually transmitted and blood-borne infections (STBBI). We also want to know how access to drug treatment and harm reduction services (such as addictions counselling and needle distribution programs) have been affected.
